WILMINGTON, Del. (AP) – Dupont shareholders on Wednesday flatly rejected a contentious campaign by one of the most powerful investor firms in the U.S. for seats on the board of the 212-year-old chemical company.
Nelson Peltz and his Trian Fund Management L.P., a major shareholder, had sought more influence at DuPont, saying that the company was falling short of its potential. CEO Ellen Kullman has resisted Peltz’s campaign vigorously, saying that he had mischaracterizing DuPont’s performance.
DuPont shares slumped 6 percent in morning trading.
Kullman said the proxy fight showed that DuPont needs to do a better job explaining its ongoing transformation from a traditional chemicals company to a growth company focused on developing advanced materials, bio-based industrial products, and new seed, food and agricultural products to improve the global food supply.
“I think we as a company don’t tell our story well enough,” she said. “We’ve undergone a lot of change, and as we’ve engaged with shareholders, even retail, it was clear that they remembered a company of maybe 20 years ago, not the company that we’re creating going forward.”
